DIR Return Create A Forum - Home
       ---------------------------------------------------------
       MS Speaks
  HTML https://msspeaks.createaforum.com
       ---------------------------------------------------------
       *****************************************************
   DIR MS Speaks
       *****************************************************
   DIR (Abst.) Ocrelizumab in people w/primary progressive MS...
       0 replies
   DIR Subcutaneous Ocrevus gets EU approval
       1 replies
   DIR Ocrelizumab-associated enteritis in patients w/MS: An emerging...
       0 replies
   DIR (Abst.) Ocrelizumab in highly disabled progressive MS patients
       0 replies
   DIR (Abst.) Neutropenia complications from ocrelizumab and rituxim...
       0 replies
   DIR (JAMA) Rituximab vs ocrelizumab in RRMS
       4 replies
   DIR (ECTRIMS) Ocrevus benefit confirmed in patients over 60 with MS
       0 replies
   DIR Phase III trial:  Ocrevus twice yearly w/10-minute subcutaneou...
       3 replies
   DIR (Abst.) Severe U. urealyticum infection in patient w/ocrelizum...
       0 replies
   DIR (ACTRIMS2023) Delays in Ocrevus infusions not tied to greater ...
       0 replies
       *****************************************************
   DIR Next Page